Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18-25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT).

Vaccine · 2025 · PMC11894763 · PMID 39961279

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

2 – 3 ); however, the evaluation for a linear trend did not reach statistical significance due to the modest sample size within age-stratified analysis ( Supplementary Tables 8–9 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.